• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EMT 相关长链非编码 RNA 在三阴性乳腺癌转移过程中的作用。

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.

机构信息

Department of Thyroid and Breast Surgery, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Fengcheng 3rd Road 10, Weiyang District, Xi'an, Shaanxi 710018, P. R. China.

Department of Radiotherapy, The First Affiliated Hospital of Xi'an Jiaotong University, Yanta West Road 277, Yanta District, Xi'an, Shaanxi 710061, P. R. China.

出版信息

Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20203121.

DOI:10.1042/BSR20203121
PMID:33443534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7859322/
Abstract

Triple-negative breast cancer (TNBC) is the most malignant and fatal subtype of breast cancer, which has characterized by negativity expression of ER, PR, and HER2. Metastasis is the main factor affecting the prognosis of TNBC, and the process of metastasis is related to abnormal activation of epithelial-mesenchymal transition (EMT). Recent studies have shown that long non-coding RNA (LncRNA) plays an important role in regulating the metastasis and invasion of TNBC. Therefore, based on the metastasis-related EMT signaling pathway, great efforts have confirmed that LncRNA is involved in the molecular mechanism of TNBC metastasis, which will provide new strategies to improve the treatment and prognosis of TNBC. In this review, we summarized many signal pathways related to EMT involved in the transfer process. The advances from the most recent studies of lncRNAs in the EMT-related signal pathways of TNBC metastasis. We also discussed the clinical research, application, and challenges of LncRNA in TNBC.

摘要

三阴性乳腺癌(TNBC)是乳腺癌中最恶性和致命的亚型,其特征为 ER、PR 和 HER2 的阴性表达。转移是影响 TNBC 预后的主要因素,而转移过程与上皮-间充质转化(EMT)的异常激活有关。最近的研究表明,长链非编码 RNA(LncRNA)在调节 TNBC 的转移和侵袭中发挥重要作用。因此,基于转移相关的 EMT 信号通路,大量研究已经证实 LncRNA 参与了 TNBC 转移的分子机制,这将为改善 TNBC 的治疗和预后提供新的策略。在这篇综述中,我们总结了 EMT 转移过程中涉及的许多信号通路。讨论了 LncRNA 在 TNBC 转移的 EMT 相关信号通路中的最新研究进展。我们还讨论了 LncRNA 在 TNBC 中的临床研究、应用和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e60/7859322/16e15a5a0483/bsr-41-bsr20203121-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e60/7859322/18b87d57673b/bsr-41-bsr20203121-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e60/7859322/16e15a5a0483/bsr-41-bsr20203121-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e60/7859322/18b87d57673b/bsr-41-bsr20203121-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e60/7859322/16e15a5a0483/bsr-41-bsr20203121-g2.jpg

相似文献

1
The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.EMT 相关长链非编码 RNA 在三阴性乳腺癌转移过程中的作用。
Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20203121.
2
Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.长链非编码 RNA ZEB2-AS1 通过表观遗传激活 ZEB2 促进三阴性乳腺癌的增殖、转移和上皮间质转化。
J Cell Mol Med. 2019 May;23(5):3271-3279. doi: 10.1111/jcmm.14213. Epub 2019 Mar 1.
3
Long noncoding RNAs (lncRNAs) in triple negative breast cancer.三阴性乳腺癌中的长非编码 RNA(lncRNA)。
J Cell Physiol. 2017 Dec;232(12):3226-3233. doi: 10.1002/jcp.25830. Epub 2017 Feb 21.
4
Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer.携带工程化干扰长非编码 RNA 的溶瘤病毒治疗通过阻断三阴性乳腺癌中的上皮间质转化发挥抗肿瘤活性。
Cancer Lett. 2020 Jun 1;479:42-53. doi: 10.1016/j.canlet.2020.03.012. Epub 2020 Mar 19.
5
LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.长链非编码 RNA DANCR 通过 TUFT1 上调促进三阴性乳腺癌的恶性进展,通过 miR-874-3p-SOX2 轴。
Exp Cell Res. 2020 Nov 15;396(2):112331. doi: 10.1016/j.yexcr.2020.112331. Epub 2020 Oct 13.
6
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.甲磺酸艾日布林通过使上皮-间质转化(EMT)状态向间质-上皮转化(MET)状态逆转,抑制乳腺癌细胞的实验性转移。
Br J Cancer. 2014 Mar 18;110(6):1497-505. doi: 10.1038/bjc.2014.80. Epub 2014 Feb 25.
7
SBF2-AS1 and TreRNA: novel lncRNA players in triple-negative breast cancer pathogenesis.SBF2-AS1 和 TreRNA:三阴性乳腺癌发病机制中的新型 lncRNA 分子。
Mol Biol Rep. 2023 Jul;50(7):6029-6037. doi: 10.1007/s11033-023-08533-y. Epub 2023 Jun 7.
8
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.微小RNA-124基于锌指E盒结合同源盒蛋白2靶点调控上皮-间质转化,以抑制三阴性乳腺癌的侵袭和转移。
Pathol Res Pract. 2019 Apr;215(4):697-704. doi: 10.1016/j.prp.2018.12.039. Epub 2018 Dec 31.
9
SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.SIRT1通过靶向上皮-间质转化相关途径诱导肿瘤侵袭,并且是三阴性乳腺癌中的一个预后标志物。
Tumour Biol. 2016 Apr;37(4):4743-53. doi: 10.1007/s13277-015-4231-3. Epub 2015 Oct 30.
10
Activation of epithelial-mesenchymal transition process during breast cancer progression - the impact of molecular subtype and stromal composition.乳腺癌进展过程中上皮-间质转化过程的激活——分子亚型和基质组成的影响
Acta Biochim Pol. 2021 Aug 25;68(3):385-392. doi: 10.18388/abp.2020_5719.

引用本文的文献

1
Non-coding RNAs as key regulators of epithelial-mesenchymal transition in breast cancer.非编码RNA作为乳腺癌上皮-间质转化的关键调节因子
Front Cell Dev Biol. 2025 Mar 25;13:1544310. doi: 10.3389/fcell.2025.1544310. eCollection 2025.
2
The Role of the Fox Gene in Breast Cancer Progression.Fox基因在乳腺癌进展中的作用。
Int J Mol Sci. 2025 Feb 7;26(4):1415. doi: 10.3390/ijms26041415.
3
Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.

本文引用的文献

1
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.勘误:AFAP1-AS1通过Wnt/β-连环蛋白信号通路促进三阴性乳腺癌的上皮-间质转化和肿瘤发生。
Front Pharmacol. 2020 Jul 20;11:1107. doi: 10.3389/fphar.2020.01107. eCollection 2020.
2
Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression.长链非编码RNA OIP5-AS1通过吸附miR-27a-3p激活TSC1表达来抑制多发性骨髓瘤进展。
Cancer Cell Int. 2020 May 7;20:155. doi: 10.1186/s12935-020-01234-7. eCollection 2020.
3
探讨循环长链非编码 RNA 在乳腺癌中的临床潜力:原发性信号通路和治疗干预的新见解。
Funct Integr Genomics. 2024 Nov 7;24(6):209. doi: 10.1007/s10142-024-01476-y.
4
Epithelial-Mesenchymal Transition Indexes in Triple-Negative Breast Cancer Progression and Metastases.三阴性乳腺癌进展和转移中的上皮-间质转化指标
Cureus. 2024 Sep 6;16(9):e68761. doi: 10.7759/cureus.68761. eCollection 2024 Sep.
5
Deciphering the code: the pivotal role of lncRNAs in advancing TNBC therapy.破解密码:长链非编码RNA在推进三阴性乳腺癌治疗中的关键作用。
Front Oncol. 2024 Sep 2;14:1450980. doi: 10.3389/fonc.2024.1450980. eCollection 2024.
6
Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.单细胞分析揭示转移性乳腺癌的肿瘤内和肿瘤间异质性。
J Mammary Gland Biol Neoplasia. 2023 Dec 8;28(1):26. doi: 10.1007/s10911-023-09551-z.
7
An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.一个 EMT 相关基因标志物作为子宫内膜癌患者的预后生物标志物。
BMC Cancer. 2023 Sep 18;23(1):879. doi: 10.1186/s12885-023-11358-4.
8
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics.CRISPR/Cas9作为三阴性乳腺癌的治疗工具:从实验台到临床应用
Front Mol Biosci. 2023 Jul 4;10:1214489. doi: 10.3389/fmolb.2023.1214489. eCollection 2023.
9
EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?癌症中的 EMT/MET 可塑性与静止期的 Go-or-Grow 决策:同一枚硬币的两面?
Mol Cancer. 2023 May 31;22(1):90. doi: 10.1186/s12943-023-01793-z.
10
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.FRA-1 作为乳腺癌 EMT 和转移的调节因子。
Int J Mol Sci. 2023 May 5;24(9):8307. doi: 10.3390/ijms24098307.
LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway.
长链非编码RNA EGOT通过 Hedgehog信号通路失活降低乳腺癌细胞的活力和迁移能力。
FEBS Open Bio. 2020 May;10(5):817-826. doi: 10.1002/2211-5463.12833. Epub 2020 Apr 8.
4
Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1/Notch/NRP1 signaling circuit at a tumor microenvironment.Linc-OIP5 在乳腺癌细胞中通过肿瘤微环境中的 YAP1/Notch/NRP1 信号通路调节人脐静脉内皮细胞的血管生成。
Biol Res. 2020 Feb 11;53(1):5. doi: 10.1186/s40659-020-0273-0.
5
Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.长链非编码 RNA CCAT2 通过调节癌细胞的干性促进三阴性乳腺癌的发生。
Pharmacol Res. 2020 Feb;152:104628. doi: 10.1016/j.phrs.2020.104628. Epub 2020 Jan 3.
6
loss regulates migration and invasion in MDA-MB-231 breast cancer cells by inhibiting YAP1/JAG1 signaling.Loss通过抑制YAP1/JAG1信号通路调节MDA-MB-231乳腺癌细胞的迁移和侵袭。
Oncol Lett. 2020 Jan;19(1):103-112. doi: 10.3892/ol.2019.11071. Epub 2019 Nov 8.
7
Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications.长链非编码RNA:对乳腺癌转移的双重影响及临床应用
Cancers (Basel). 2019 Nov 16;11(11):1802. doi: 10.3390/cancers11111802.
8
Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges.基于纳米颗粒的药物输送和基因治疗乳腺癌:最新进展和未来挑战。
Semin Cancer Biol. 2021 Feb;69:226-237. doi: 10.1016/j.semcancer.2019.10.020. Epub 2019 Nov 5.
9
LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells.长链非编码 RNA WT1-AS 通过上调 p53 抑制宫颈鳞癌细胞的增殖。
BMC Cancer. 2019 Nov 6;19(1):1052. doi: 10.1186/s12885-019-6264-2.
10
LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.长链非编码 RNA WT1-AS 通过下调转化生长因子 β1 抑制三阴性乳腺癌细胞迁移和侵袭。
Cancer Biother Radiopharm. 2019 Dec;34(10):671-675. doi: 10.1089/cbr.2019.2925. Epub 2019 Oct 17.